Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

DEPLETION OF SIV-SPECIFIC CD8+ T CELLS DOES NOT ALTER VIRAL LOAD DURING SIV INFECTION

By Jimmy He PharmD, DScMarch 24, 2023

…control of viremia to < 10,000 copies/mL. Lymphocyte populations in blood, bronchoalveolar lavage fluid, lymph nodes, colon, and jejunum were enumerated via flow cytometry. Plasma viremia was measured via quantitative…

349 – IL-10 and IFN Signaling Define Epigenetic States Linked to HIV Persistence in Memory CD4+ T Cells

By Jimmy He PharmD, DScMarch 31, 2026

…vDNA+ cells. In addition, SIV-infected RMs treated with aIL-10 vs control group were compared for their vRNA and vDNA levels in lymph nodes (LNs); scRNA-seq and scATAC-seq was also performed…

625 – Kaposi Sarcoma, With and Without Pulmonary Involvement: Clinical Differences and Outcomes

By Jimmy He PharmD, DScMarch 31, 2026

…and outcomes of patients with disseminated KS, with and without pulmonary involvement. Methods We conducted a single-center retrospective cohort study from 2018 to 2024, including people with HIV and biopsy-confirmed…

SYSTEMIC ACTIVATION OF NOVEL IGA+ NATURAL KILLER-LIKE B CELLS IN HIV/SIV INFECTIONS

By Enthusiast Inc MDMarch 5, 2018

Recently, a novel innate immune cell subset termed natural killer-like B (NKB) cells was identified in mice that rapidly responded to microbial infection and primed the innate antiviral response. Despite…

Low SKAP1 Levels Indicate a Potential New Mechanism in HIV Immunological Non-Responders

By Jimmy He PharmD, DScMarch 6, 2024

…impaired CD4+ T-cell migration to the intestine and lymph nodes. SKAP1 has never been described in the context of HIV. Methods: The 2000HIV study (clinicaltrials NTC03994835) is a Dutch cross-omics…

627 – Presence of Kaposi Sarcoma–Associated Herpesvirus Tissue Reservoirs in Seronegative Postmortem Cases

By Jimmy He PharmD, DScMarch 31, 2026

…KSHV DNA in multiple anatomic sites, such as oral cavity, respiratory tract, kidney and lymph nodes. The KSHV seronegativity of these 7 donors was further confirmed with ultra-sensitive serological assay VirScan.  Conclusions…

Pol Versus Env Genetics in SHIV-Infected Macaques Highlights Importance of Phylogenetic Signal

By Enthusiast Inc MDSeptember 29, 2014

…pol masked the emergence of new viral variants and/or compartmentalization, we applied the same methods to the more diverse env gene in the infected macaques. Methodology: Two macaques (M03250 and…

461 – Gut Microbiome Dynamics and Immune Responses in People With HIV Receiving N-803

By Jimmy He PharmD, DScMarch 20, 2025

…metagenomic sequencing was performed to analyze taxonomic composition and functional profiles of the gut microbiota bioinformatically. We also investigated associations between microbial diversity and immune markers, including NKG2A, viral (v)RNA…

NEUROLOGIC CONSEQUENCES OF POSTNATAL ZIKA VIRUS INFECTION IN INFANTS

By Enthusiast Inc MDFebruary 16, 2017

…in infants and another subset was followed longitudinally. Viral loads in plasma and tissues were measured by qPCR. Binding and neutralization antibody responses were quantified by ELISA and focus reduction…

IL-7 AND IL-15 IMPROVE HUMORAL RESPONSES OF A SHIV DNA VACCINE IN ANIMAL MODELS

By Jimmy He PharmD, DScApril 4, 2022

…backbone of SHIV-KU2, lacking the integrase gene. In our earlier studies we demonstrated persistent Gag- and Nef-specific CD4+ and CD8+ T precursors (PHPC), central memory (Tcm) and effector memory (Tem)…

←1
234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253545556575859606162636465666768697071727374757677
…787980818283→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top